Market Analysts see Asensus Surgical Inc. [ASXC] gaining to $1.50. Time to buy?

Asensus Surgical Inc. [AMEX: ASXC] surged by $0.07 during the normal trading session on Thursday and reaching a high of $0.40 during the day while it closed the day at $0.36. The company report on September 7, 2023 at 6:55 AM that Asensus Surgical Announces Collaboration with NVIDIA to Enhance Augmented Intelligence Capabilities of the ISU.

Asensus will utilize a broad suite of NVIDIA tools to enhance the augmented intelligence capabilities of its ISU. Asensus’s ISU is built with NVIDIA accelerated computing technology and has been bringing real-time augmented intelligent features — such as digital tags, 3D measurement, and enhanced camera control — to surgeons since 2021.

Top 5 EV Tech Stocks to Buy for 2023

The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".

Click Here to Download the FREE Report.


Asensus Surgical Inc. stock has also gained 22.34% of its value over the past 7 days. However, ASXC stock has declined by -32.88% in the 3 months of the year. Over the past six months meanwhile, it has lost -47.02% and gained 2.56% year-on date.

The market cap for ASXC stock reached $94.29 million, with 263.87 million shares outstanding and 259.20 million shares in the current float. Compared to the average trading volume of 1.59M shares, ASXC reached a trading volume of 58704093 in the most recent trading day, which is why market watchdogs consider the stock to be active.

Here’s what leading stock market gurus have to say about Asensus Surgical Inc. [ASXC]:

Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for ASXC shares is $1.50 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on ASXC stock is a recommendation set at 2.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.

Cantor Fitzgerald have made an estimate for Asensus Surgical Inc. shares, keeping their opinion on the stock as Overweight, with their previous recommendation back on September 08, 2022.

The Average True Range (ATR) for Asensus Surgical Inc. is set at 0.04, with the Price to Sales ratio for ASXC stock in the period of the last 12 months amounting to 13.28. The Price to Book ratio for the last quarter was 1.37, with the Price to Cash per share for the same quarter was set at 0.15.

ASXC stock trade performance evaluation

Asensus Surgical Inc. [ASXC] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 22.34. With this latest performance, ASXC shares gained by 6.30% in over the last four-week period, additionally sinking by -47.02% over the last 6 months – not to mention a drop of -30.86% in the past year of trading.

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for ASXC stock in for the last two-week period is set at 56.60, with the RSI for the last a single of trading hit 68.61, and the three-weeks RSI is set at 49.98 for Asensus Surgical Inc. [ASXC]. The present Moving Average for the last 50 days of trading for this stock 0.3950, while it was recorded at 0.3078 for the last single week of trading, and 0.5414 for the last 200 days.

Asensus Surgical Inc. [ASXC]: An insightful look at the core fundamentals

Operating Margin for any stock indicates how profitable investing would be, and Asensus Surgical Inc. [ASXC] shares currently have an operating margin of -1063.40 and a Gross Margin at -162.17. Asensus Surgical Inc.’s Net Margin is presently recorded at -1066.19.

Return on Total Capital for ASXC is now -53.81, given the latest momentum, and Return on Invested Capital for the company is -54.24. Return on Equity for this stock declined to -56.20, with Return on Assets sitting at -49.22. When it comes to the capital structure of this company, Asensus Surgical Inc. [ASXC] has a Total Debt to Total Equity ratio set at 5.56. Additionally, ASXC Total Debt to Total Capital is recorded at 5.27, with Total Debt to Total Assets ending up at 4.72. Long-Term Debt to Equity for the company is recorded at 4.75, with the Long-Term Debt to Total Capital now at 4.50.

Reflecting on the efficiency of the workforce at the company, Asensus Surgical Inc. [ASXC] managed to generate an average of -$383,558 per employee. Receivables Turnover for the company is 4.72 with a Total Asset Turnover recorded at a value of 0.05.Asensus Surgical Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 4.30 and a Current Ratio set at 5.20.

Asensus Surgical Inc. [ASXC]: Institutional Ownership

The top three institutional holders of ASXC stocks are: VANGUARD GROUP INC with ownership of 1.31 billion shares, which is approximately 8.2089%. BLACKROCK INC., holding 1.04 billion shares of the stock with an approximate value of $170.67 trillion in ASXC stocks shares; and BERKSHIRE HATHAWAY INC, currently with $150.98 trillion in ASXC stock with ownership which is approximately 5.7381%.

Leave a Comment

Your email address will not be published. Required fields are marked *